| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Daniel van Dijk, Maarten W J Koeter, Ron Hijman, René S Kahn, Wim van den Brin. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophrenia research. vol 137. issue 1-3. 2012-09-18. PMID:22313726. |
effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. |
2012-09-18 |
2023-08-12 |
Not clear |
| Daniel van Dijk, Maarten W J Koeter, Ron Hijman, René S Kahn, Wim van den Brin. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophrenia research. vol 137. issue 1-3. 2012-09-18. PMID:22313726. |
findings on the impact of cannabis use on the course of schizophrenia are inconsistent and not conclusive. |
2012-09-18 |
2023-08-12 |
Not clear |
| Deidre M Anglin, Cheryl M Corcoran, Alan S Brown, Henian Chen, Quenesha Lighty, Judith S Brook, Patricia R Cohe. Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood. Schizophrenia research. vol 137. issue 1-3. 2012-09-18. PMID:22325079. |
while increasing evidence suggests that cannabis use may play a role in the development of schizophrenia in some young people, less is known about the strength and specificity of its relationship to latent schizophrenia liability, i.e., schizotypal personality disorder traits. |
2012-09-18 |
2023-08-12 |
Not clear |
| E Manrique-Garcia, S Zammit, C Dalman, T Hemmingsson, S Andreasson, P Allebec. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. Psychological medicine. vol 42. issue 6. 2012-09-07. PMID:21999906. |
cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort. |
2012-09-07 |
2023-08-12 |
Not clear |
| Carissa M Coulston, Michael Perdices, Antony F Henderson, Gin S Malh. Cannabinoids for the treatment of schizophrenia? A balanced neurochemical framework for both adverse and therapeutic effects of cannabis use. Schizophrenia research and treatment. vol 2011. 2012-08-31. PMID:22937266. |
this paper details a review of the neurobiological substrates of schizophrenia and the neurochemical effects of cannabis use in the normal population, in both cortical (in particular prefrontal) and subcortical brain regions. |
2012-08-31 |
2023-08-12 |
Not clear |
| Sandeep Grover, Debasish Bas. Cannabis and psychopathology : update 2004. Indian journal of psychiatry. vol 46. issue 4. 2012-08-30. PMID:21206788. |
psychopathology and psychiatric syndromes associated with cannabis use that have received research attention in recent years include cannabis withdrawal, cannabis and psychotic disorders (especially schizophrenia), depression, anxiety, and cognitive impairment. |
2012-08-30 |
2023-08-12 |
Not clear |
| Sandeep Grover, Debasish Bas. Cannabis and psychopathology : update 2004. Indian journal of psychiatry. vol 46. issue 4. 2012-08-30. PMID:21206788. |
cannabis use might be casually related to the later development of schizophrenia in an indirect way in a few heavy users, but more commonly, its use may precipitate disorders in persons who are vulnerable to developing psychosis and worsen the course of the disorder. |
2012-08-30 |
2023-08-12 |
Not clear |
| Marise Machielsen, Albertine Scheltema Beduin, Nienke Dekker, René S Kahn, Don H Linszen, Jim van Os, Durk Wiersma, Richard Bruggeman, Wiepke Cahn, Lieuwe de Haan, Lydia Krabbendam, Inez Myin-Germey. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of psychopharmacology (Oxford, England). vol 26. issue 1. 2012-08-21. PMID:21768161. |
differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. |
2012-08-21 |
2023-08-12 |
human |
| Ruth Weissenborn, David J Nut. Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? Journal of psychopharmacology (Oxford, England). vol 26. issue 2. 2012-08-21. PMID:21926420. |
it is argued that increased policing of cannabis use under the current drug classification system will lead to increased criminalization of young people, but is unlikely to significantly reduce the rates of schizophrenia and psychosis. |
2012-08-21 |
2023-08-12 |
Not clear |
| Gemma Nicoll, Scott Davidson, Lynne Shanley, Ben Hing, Marissa Lear, Peter McGuffin, Ruth Ross, Alasdair MacKenzi. Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus. The Journal of biological chemistry. vol 287. issue 16. 2012-06-19. PMID:22362764. |
intriguingly, rs9444584 is in strong linkage disequilibrium with two other snps (rs9450898 (r(2) = 0.841) and rs2023239 (r(2) = 0.920)) that have been associated with addiction, obesity (rs2023239), and reduced fronto-temporal white matter volumes in schizophrenia patients as a result of cannabis misuse (rs9450898). |
2012-06-19 |
2023-08-12 |
Not clear |
| Murat Yücel, Emre Bora, Dan I Lubman, Nadia Solowij, Warrick J Brewer, Sue M Cotton, Philippe Conus, Michael J Takagi, Alex Fornito, Stephen J Wood, Patrick D McGorry, Christos Panteli. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia bulletin. vol 38. issue 2. 2012-06-12. PMID:20660494. |
the impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. |
2012-06-12 |
2023-08-12 |
Not clear |
| Murat Yücel, Emre Bora, Dan I Lubman, Nadia Solowij, Warrick J Brewer, Sue M Cotton, Philippe Conus, Michael J Takagi, Alex Fornito, Stephen J Wood, Patrick D McGorry, Christos Panteli. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia bulletin. vol 38. issue 2. 2012-06-12. PMID:20660494. |
however, while heavy cannabis use has been associated with cognitive deficits in long-term users, studies among patients with schizophrenia have been contradictory. |
2012-06-12 |
2023-08-12 |
Not clear |
| Murat Yücel, Emre Bora, Dan I Lubman, Nadia Solowij, Warrick J Brewer, Sue M Cotton, Philippe Conus, Michael J Takagi, Alex Fornito, Stephen J Wood, Patrick D McGorry, Christos Panteli. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia bulletin. vol 38. issue 2. 2012-06-12. PMID:20660494. |
in study i, a meta-analysis of 10 studies comprising 572 patients with established schizophrenia (with and without comorbid cannabis use) was conducted. |
2012-06-12 |
2023-08-12 |
Not clear |
| Murat Yücel, Emre Bora, Dan I Lubman, Nadia Solowij, Warrick J Brewer, Sue M Cotton, Philippe Conus, Michael J Takagi, Alex Fornito, Stephen J Wood, Patrick D McGorry, Christos Panteli. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia bulletin. vol 38. issue 2. 2012-06-12. PMID:20660494. |
together, these findings suggest that patients with schizophrenia or fep with a history of cannabis use have superior neuropsychological functioning compared with nonusing patients. |
2012-06-12 |
2023-08-12 |
Not clear |
| Murat Yücel, Emre Bora, Dan I Lubman, Nadia Solowij, Warrick J Brewer, Sue M Cotton, Philippe Conus, Michael J Takagi, Alex Fornito, Stephen J Wood, Patrick D McGorry, Christos Panteli. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia bulletin. vol 38. issue 2. 2012-06-12. PMID:20660494. |
this association between better cognitive performance and cannabis use in schizophrenia may be driven by a subgroup of "neurocognitively less impaired" patients, who only developed psychosis after a relatively early initiation into cannabis use. |
2012-06-12 |
2023-08-12 |
Not clear |
| Sanjiv Kumra, Paul Robinson, Rabindra Tambyraja, Daniel Jensen, Caroline Schimunek, Alaa Houri, Tiffany Reis, Kelvin Li. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. Journal of the American Academy of Child and Adolescent Psychiatry. vol 51. issue 2. 2012-06-07. PMID:22265363. |
parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. |
2012-06-07 |
2023-08-12 |
Not clear |
| Sanjiv Kumra, Paul Robinson, Rabindra Tambyraja, Daniel Jensen, Caroline Schimunek, Alaa Houri, Tiffany Reis, Kelvin Li. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. Journal of the American Academy of Child and Adolescent Psychiatry. vol 51. issue 2. 2012-06-07. PMID:22265363. |
early exposure to cannabis may represent an environmental risk factor for developing schizophrenia. |
2012-06-07 |
2023-08-12 |
Not clear |
| Hideto Tsuchida, Isao Nishimura, Kenji Fuku. [Alcohol and substance dependence]. Brain and nerve = Shinkei kenkyu no shinpo. vol 64. issue 2. 2012-04-26. PMID:22308261. |
furthermore, amotivational syndrome, which is observed in patients with chronic cannabis and organic solvent dependence, is similar to the negative symptoms of schizophrenia. |
2012-04-26 |
2023-08-12 |
Not clear |
| J Michael Bostwic. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clinic proceedings. vol 87. issue 2. 2012-03-26. PMID:22305029. |
pubmed searches were conducted using the following keywords: medical marijuana, medical cannabis, endocannabinoid system, cb1 receptors, cb2 receptors, thc, cannabidiol, nabilone, dronabinol, nabiximols, rimonabant, marijuana legislation, marijuana abuse, marijuana dependence, and marijuana and schizophrenia. |
2012-03-26 |
2023-08-12 |
human |
| Nienke Dekker, Lieuwe de Haan, Sake van den Berg, Martin de Gier, Hiske Becker, Don H Linze. Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders. Psychopharmacology bulletin. vol 41. issue 1. 2012-03-13. PMID:18362877. |
cessation of cannabis use by patients with recent-onset schizophrenia and related disorders. |
2012-03-13 |
2023-08-12 |
Not clear |